FindTrial
Sign In

to study and compare two regional blocks for breast cancer surgery

to study and compare the efficiency of erector spinae block vs pectoralis nerve block for post operative analgesia in breast cancer surgery:a prospective randomised control trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/01/049272
Enrollment
64
Registered
2023-01-30
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified site Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: pectoralis nerve block and erector spinae block: one group will receive ESP block using 30 ml of 0.25% Bupivacaine and other group will receive PECS (I and II) block using 30 ml 0.25% B

Sponsors

Dept of Anaesthesia and critical care
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: all patient will undergo breast cancer surgery ASA I or ASA II

Exclusion criteria

Exclusion criteria: Local infection at the block site coagulopathy autoimmune disease morbid obesity chest wall deformity psychiatric illness

Design outcomes

Primary

MeasureTime frame
time duration and intensity of pain post block using NRS and VAS scoreTimepoint: first 24 hours post op—

Secondary

MeasureTime frame
to compare any complication associated with the blocks in the two groupsTimepoint: 1 year—

Countries

India

Contacts

Public ContactM SNEHA PRIYA

command hospital central command , lucknow

sanab1991@yahoo.com9876468707

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026